$CI has released its earnings report for Q4 2024, revealing key financial metrics. The company achieved revenue growth of 27% to $247 billion, with adjusted EPS of $27.33, a 9% increase YoY, but slightly below expectations. Risks include higher medical costs in their stop-loss product, projected to impact margin recovery.